NovoCure Limited (NASDAQ:NVCR) Given Consensus Rating of “Hold” by Analysts

Shares of NovoCure Limited (NASDAQ: NVCR - Get Free Report) have received an average rating of "Hold" from the seven ratings firms that are currently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and three have assigned a buy recommendation to the